glp 1 medications and depression GLP-1 drugs tied to lower brain inflammation, higher risk Risk of depression with GLP‐1

File File history File usage on Commons File usage on other wikis Metadata Original file (1,024 683 pixels, file size: 579 KB, MIME type: image/jpeg) File information Structured data Captions Captions Add a one-line explanation of what this file represents File history You cannot overwrite this file

Diabetes Obes Metab 24(5):769787

results showing that oral GLP-1 agonist orforglipron significantly reduced A1C at all doses and induced weight loss at 12 mg and 36 mg versus placebo, with a safety profile consistent with the GLP-1 class

It may also induce psychosis in those at high risk of developing psychiatric disorders such as Bipolar Disorder or Schizophrenia

Its important to know that GLP-1s should not be taken only to lower the risk of cancer